Ticker brief
AMGN AMGEN INC
Consumer, Non-cyclical · Biotechnology
last close
$439.26
1 day
-1.8%
14 days
+5.9%
mkt cap
$201.9B
signals 14d
37
authors 14d
25
crowd 14d
+0.5σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 33% rich · 96 pctile own 1y | IV/HV 1.23× |
| Skew — 25Δ RR 30d | -0.027 57 pctile own 1y | balanced vs own range |
| Net dealer OI (NDOI) | +0.38 normal | 5-session Δ +0.07 (as of 2026-07-06) |
| OI alarm | quiet | last alarm 2025-01-10 (z=2.1) |
| Next earnings | 2026-11-03 (proj) | in 8d |
| CSP screen | rank #88 · $422.5 strike · 0.09% prem | on the CSP screen (2026-10-23) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-03 → 2026-10-15 · now +0.24 (−1 bearish … +1 bullish)
Who spoke25
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @bioinvestor24 | A | -0.87 | 6 | -0.34 |
| @BoggleRiley | C | +0.59 | 6 | +0.36 |
| @matt2cents | C | -1.42 | 2 | +0.35 |
| @AryaFintech | C | -1.41 | 2 | +0.20 |
| @StockWorthyApp | C | -0.77 | 1 | +0.00 |
| @EquityClock | A | -0.07 | 1 | -0.30 |
| @fwpharma | B | -1.91 | 1 | +0.05 |
| @TamirTiko2110 | C | -2.13 | 1 | +0.35 |
| @schaeffers | C | +1.18 | 1 | +0.40 |
| @WOLF_Financial | C | -3.03 | 1 | +0.25 |
| @semodough | C | -1.06 | 1 | +0.40 |
| @AIStockSavvy | C | -1.05 | 1 | +0.20 |
| @snorlax_uw | C | · | 1 | +0.00 |
| @VolumeLeaders | A | +0.57 | 1 | +0.00 |
| @Amgen | C | · | 1 | +0.15 |
| @MikeZaccardi | B | +0.60 | 1 | +0.20 |
| @TalkMarkets | C | · | 1 | +0.40 |
| @HedgeFundTips | B | +0.73 | 1 | +0.00 |
| @Couzin_Vinny | C | -1.03 | 1 | +0.25 |
| @everytimeicash | B | -0.87 | 1 | +0.35 |
| @momiage0088 | C | -0.49 | 1 | +0.30 |
| @MonacoMacro | B | +1.23 | 1 | +0.45 |
| @Trading_Sunset | C | -2.68 | 1 | +0.20 |
| @twinsight_x | C | +2.87 | 1 | +0.40 |
| @ClassicRoy | C | -1.10 | 1 | +0.00 |
Recent signals30of 37 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-15 | @ClassicRoy | +0.00 | Associates a six-name basket with stagflation warning signs but gives no clear direction. | +1.2% | tweet ↗ |
| 2026-10-15 | @BoggleRiley | +0.25 | Recaps the day's board performance and successful morning picks. | +1.2% | tweet ↗ |
| 2026-10-15 | @BoggleRiley | +0.35 | Reports opening performance and favors the defense names holding green. | +1.2% | tweet ↗ |
| 2026-10-15 | @twinsight_x | +0.40 | Health-care strength versus semiconductor weakness is identified as a continuing rotation. | +1.2% | tweet ↗ |
| 2026-10-15 | @Trading_Sunset | +0.20 | Premarket market scan identifies relative strength and weakness while equity futures lean weak. | +1.2% | tweet ↗ |
| 2026-10-14 | @MonacoMacro | +0.45 | Reports healthcare outperforming on CPI day and attributes rotation to steady earnings and pricing power. | +3.1% | tweet ↗ |
| 2026-10-14 | @momiage0088 | +0.30 | Reports an attack on an Aramco facility, oil prices, healthcare gains, gold performance, and upcoming data. | +3.1% | tweet ↗ |
| 2026-10-14 | @BoggleRiley | +0.40 | Recaps daily moves and successful morning picks after the close. | +3.1% | tweet ↗ |
| 2026-10-14 | @everytimeicash | +0.35 | Identifies a defensive rotation into pharma and value retail. | +3.1% | tweet ↗ |
| 2026-10-14 | @Couzin_Vinny | +0.25 | Expects a dealer-driven MRK squeeze after moving above the $145 call wall. | +3.1% | tweet ↗ |
| 2026-10-14 | @BoggleRiley | +0.35 | Reports defense stocks holding gains while space names decline. | +3.1% | tweet ↗ |
| 2026-10-13 | @HedgeFundTips | +0.00 | Shares a chart covering biotech earnings estimates and revisions. | +6.4% | tweet ↗ |
| 2026-10-12 | @TalkMarkets | +0.40 | Favors larger-cap biotech names until sector momentum returns. | +5.2% | tweet ↗ |
| 2026-10-09 | @bioinvestor24 | -0.25 | Expresses skepticism about AMGN's molecule and antibody-related production prospects. | +5.9% | tweet ↗ |
| 2026-10-09 | @MikeZaccardi | +0.20 | Six Dow components are cited as positive contributors to index leadership. | +5.9% | tweet ↗ |
| 2026-10-09 | @bioinvestor24 | -0.15 | Dislikes Gilead management for weak science and overpaying, while viewing Amgen as middling. | +5.9% | tweet ↗ |
| 2026-10-09 | @bioinvestor24 | -0.50 | Calls AMGN and GILD the most overvalued pharma names versus peers and questions Gilead's pipeline and moat. | +5.9% | tweet ↗ |
| 2026-10-09 | @bioinvestor24 | -0.50 | Mocks Amgen for allegedly withholding maintenance data. | +5.9% | tweet ↗ |
| 2026-10-09 | @Amgen | +0.15 | Amgen announces presentation of encouraging real-world hip-bone-strength data at ASBMR 2026. | +5.9% | tweet ↗ |
| 2026-10-08 | @VolumeLeaders | +0.00 | Reports IBB's largest trade since May 2020 and lists its principal holdings. | +7.8% | tweet ↗ |
| 2026-10-08 | @bioinvestor24 | -0.30 | Assesses ZEAL weight loss as better than expected but A1C efficacy as modest amid weak obesity trials. | +7.8% | tweet ↗ |
| 2026-10-08 | @snorlax_uw | +0.00 | Lists analyst rating actions and targets; output is capped to the first six directly affected tickers. | +7.8% | tweet ↗ |
| 2026-10-08 | @AIStockSavvy | +0.20 | Cantor maintained Neutral and raised Amgen's target to $440 from $400. | +7.8% | tweet ↗ |
| 2026-10-08 | @semodough | +0.40 | Cantor raised five pharma price targets and cut BMY's target. | +7.8% | tweet ↗ |
| 2026-10-08 | @matt2cents | +0.40 | Summarizes defensive pharma strength and catalyst-driven stocks despite index weakness. | +7.8% | tweet ↗ |
| 2026-10-07 | @AryaFintech | +0.20 | Lists Nasdaq 100 heat-map winners and losers for October 7. | +6.3% | tweet ↗ |
| 2026-10-07 | @AryaFintech | +0.20 | Lists Dow 30 heat-map winners and losers for October 7. | +6.3% | tweet ↗ |
| 2026-10-07 | @matt2cents | +0.30 | Describes a defensive rotation into LLY and AMGN amid hawkish minutes and softer tech. | +6.3% | tweet ↗ |
| 2026-10-07 | @BoggleRiley | +0.35 | Recaps closing performance and asks whether UUUU's drop is a dip or trend. | +6.3% | tweet ↗ |
| 2026-10-07 | @WOLF_Financial | +0.25 | Reports the day's leading stock gains and broader sector performance. | +6.3% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.